Accelera Innovations, Inc
Accelera Innovations, Inc (ACNV) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001444144 · ACNV · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001444144 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Accelera Innovations, Inc (OTC: ACNV) has submitted 121 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001444144, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Accelera Innovations, Inc's most comprehensive regulatory disclosure. The most recent Accelera Innovations, Inc 10-K was filed on 2017-04-17 for fiscal year ending 2017. Historical ACNV 10-K annual reports are available from 2008 through 2017.
Investors researching Accelera Innovations, Inc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
ACNV SEC Filings · 8 questionsAccelera Innovations, Inc (ACNV) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 121 filings and access original documents at no cost. Accelera Innovations, Inc's CIK is 0001444144.